Who founded Kallyope?

Kallyope was founded by Tom Maniatis in 2014.

Who are Kallyope's investors?

Kallyope's investors include Dns Capital, Illumina Ventures, Lux Capital, The Column Group, Polaris Partners.

How much funding has Kallyope raised?

Kallyope has disclosed $28.1M raised across 1 round.

Where is Kallyope headquartered?

Kallyope is headquartered in New York City, US.

Kallyope

New York City, US · Founded 2014 · Delaware corporation · 5 known investors

kallyope.com ↗

Kallyope is a drug discovery and development company working on therapeutic agents for neurological and metabolic diseases. Based in New York City, it develops treatments intended to be effective and well-tolerated for patients.

BiotechDeep TechHealthtechMedical Devices

Founders & leadership

Kallyope was founded in 2014 by Tom Maniatis.

Tom ManiatisFounder

Nancy ThornberryExecutive

Kenneth ClarkExecutive

Board

Terry McGuire inBoard directorFounding Partner at Polaris Partners

Joshua Wolfe in 𝕏Board MemberPartner and Co-Founder at Lux Capital

Tim KutzkeyBoard director

William RieflinBoard director

Investors · 5

Dns CapitalChicago · $25M – $100M

Illumina VenturesFoster City

Lux CapitalNew York · $100K – $100M

The Column GroupSan Francisco · $30M

Polaris PartnersreportedBoston · $500K – $5Mvia Terry McGuire · board

Reported raises · per SEC filings

Form D private placements

$28.1M disclosed across 1 round · 2015

▶$28.1MraisedOct 2016 · 9 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

William RieflinDirector
Nancy ThornberryExecutive Officer, Director
Terry McGuireDirector
Kenneth ClarkExecutive Officer
Tom ManiatisDirector
Joshua WolfeDirector
Tim KutzkeyDirector

Offering amount: $44M
Amount sold: $28.1M
First sale: Sep 2015
Incorporated: Corporation, Delaware, 2014
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Founder mafia

4 people who came through Kallyope went on to found or lead other companies.

Josh WolfeDirectorFounded Genocea Biosciences Ian PeikonCo-Founder & Director, Platform Biology & TechnologyFounded Cajal Therapeutics Mayank AgrawalMachine Learning ResearcherFounded Proof of Human Davis TongBiotech Summer InternFounded OddsView

Competitors · 2

by search overlap

Calliotx11 shared keywordsCallio Therapeutics develops next-generation dual-payload antibody-drug conjugates (ADCs) with differentiated payload and linker technologies for targeted cancer treatment. The company's lead program is a dual-payload HER2-targeted ADC designed to deliver drug combinations to tumor cells.

Karyopharm11 shared keywordsKaryopharm is a pharmaceutical company developing drugs based on its SINE (Selective Inhibitor of Nuclear Export) technology, with medicines targeting cancers including multiple myeloma and diffuse large B-cell lymphoma. It serves patients and healthcare providers in oncology.

Companies competing with Kallyope for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Kallyope do?: Kallyope is a drug discovery and development company working on therapeutic agents for neurological and metabolic diseases. Based in New York City, it develops treatments intended to be effective and well-tolerated for patients.
Who founded Kallyope?: Kallyope was founded by Tom Maniatis in 2014.
Who are Kallyope's investors?: Kallyope's investors include Dns Capital, Illumina Ventures, Lux Capital, The Column Group, Polaris Partners.
How much funding has Kallyope raised?: Kallyope has disclosed $28.1M raised across 1 round.
Where is Kallyope headquartered?: Kallyope is headquartered in New York City, US.